Cardiovascular status of childhood cancer survivors exposed and unexposed to cardiotoxic therapy

Journal of Clinical Oncology

Volumn 30, Issue 10, 2012, Pages 1050-1057

  Lipshultz, Steven E ^a   Landy, David C ^a   Lopez Mitnik, Gabriela ^a   Lipsitz, Stuart R ^b   Hinkle, Andrea S ^c   Constine, Louis S ^c   French, Carol A ^c   Rovitelli, Amy M ^c   Proukou, Cindy ^c   Adams, M Jacob ^c   Miller, Tracie L ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANTHRACYCLINE; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; SOMATOMEDIN C;

ADOLESCENT; ADULT; ARTICLE; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; CANCER SURVIVOR; CARDIOTOXICITY; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR MALFORMATION; CARDIOVASCULAR RISK; CHILD; CHILDHOOD CANCER; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART AFTERLOAD; HEART DEATH; HEART INFARCTION; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE WALL; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SIBLING; STROKE; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADULT; ANTHRACYCLINES; ANTIBIOTICS, ANTINEOPLASTIC; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHILD; CHILD, PRESCHOOL; CHOLESTEROL; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NEOPLASMS; PEPTIDE FRAGMENTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SIBLINGS; SURVIVORS; TIME FACTORS;

EID: 84861763781     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.33.7907     Document Type: Article

References (57)

1. Mariotto AB, Rowland JH, Yabroff KR, et al: Long-term survivors of childhood cancers in the United States. Cancer Epidemiol Biomarkers Prev 18:1033-1040, 2009
2. Silverman LB, Stevenson KE, O'Brien JE, et al: Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000). Leukemia 24:320-334, 2010
3. Mertens AC, Liu Q, Neglia JP, et al: Causespecific late mortality among 5-year survivors of childhood cancer: The Childhood Cancer Survivors Study. J Natl Cancer Inst 100:1368-1379, 2008
4. Oeffinger KC, Mertens AC, Sklar CA, et al: Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355:1572-1582, 2006 (Pubitemid 44547808)
5. Möller TR, Garwicz S, Barlow L, et al: Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: A populationbased study in the Nordic countries. J Clin Oncol 19:3173-3181, 2001 (Pubitemid 32591433)
6. Mulrooney DA, Yeazel MW, Kawashima T, et al: Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: Retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ 339:b4606, 2009
7. Tukenova M, Guibout C, Oberlin O, et al: Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer. J Clin Oncol 28:1308-1315, 2010
8. Reulen RC, Winter DL, Frobisher C, et al: Long-term cause-specific mortality among survivors of childhood cancer. JAMA 304:172-179, 2010
9. Levitt G, Anazodo A, Burch M, et al: Cardiac or cardiopulmonary transplantation in childhood cancer survivors: An increasing need? Eur J Cancer 45: 3027-3034, 2009
10. Lipshultz SE, Alvarez JA, Scully RE: Anthracycline associated cardiotoxicity in survivors of childhood cancer. Heart 94:525-533, 2008 (Pubitemid 351441417)
11. Krischer JP, Epstein S, Cuthbertson DD, et al: Clinical cardiotoxicity following anthracycline treatment for childhood cancer: The Pediatric Oncology Group experience. J Clin Oncol 15:1544-1552, 1997 (Pubitemid 27167391)
12. Lipshultz SE, Colan SD, Gelber RD, et al: Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med 324:808-815, 1991
13. Lipshultz SE, Lipsitz SR, Mone SM, et al: Female sex and drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. N Engl J Med 332:1738-1743, 1995
14. Lipshultz SE, Lipsitz SR, Sallan SE, et al: Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia. J Clin Oncol 23:2629-2636, 2005 (Pubitemid 46179451)
15. Adams MJ, Lipsitz SR, Colan SD, et al: Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. J Clin Oncol 22:3139-3148, 2004 (Pubitemid 41103728)
16. Sorensen K, Levitt GA, Bull C, et al: Late anthracycline cardiotoxicity after childhood cancer: A prospective longitudinal study. Cancer 97:1991- 1998, 2003
17. Lipshultz SE, Adams MJ: Cardiotoxicity after childhood cancer: Beginning with the end in mind. J Clin Oncol 28:1276-1281, 2010
18. Shankar SM, Marina N, Hudson MM, et al: Monitoring for cardiovascular disease in survivors of childhood cancer: Report from the Cardiovascular Disease Task Force of the Children's Oncology Group. Pediatrics 121:e387-e396, 2008 (Pubitemid 351198462)
19. Talvensaari KK, Lanning M, Tapanainen P, et al: Long-term survivors of childhood cancer have an increased risk of manifesting the metabolic syndrome. J Clin Endocrinol Metab 81:3051-3055, 1996 (Pubitemid 26323907)
20. Meacham LR, Sklar CA, Li S, et al: Diabetes mellitus in long-term survivors of childhood cancer: Increased risk associated with radiation therapy-A report for the Childhood Cancer Survivor Study. Arch Intern Med 169:1381-1388, 2009
21. Meacham LR, Gurney JG, Mertens AC, et al: Body mass index in long-term adult survivors of childhood cancer: A report of the Childhood Cancer Survivor Study. Cancer 103:1730-1739, 2005 (Pubitemid 40490036)
22. Miller TL, Lipsitz SR, Lopez-Mitnik G, et al: Characteristics and determinants of adiposity in pediatric cancer survivors. Cancer Epidemiol Biomarkers Prev 19:2013-2022, 2010
23. Kavey RE, Allada V, Daniels SR, et al: Cardiovascular risk reduction in high-risk pediatric patients: A scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research-Endorsed by the American Academy of Pediatrics. Circulation 114:2710-2738, 2006
24. Hinkle AS, Proukou C, French CA, et al: A clinic-based, comprehensive care model for studying late effects in long-term survivors of pediatric illnesses. Pediatrics 113:1141-1145, 2004 (suppl 4)
25. McMahan CA, Gidding SS, Fayad ZA, et al: Risk scores predict atherosclerotic lesions in young people. Arch Intern Med 165:883-890, 2005 (Pubitemid 40563234)
26. Pencina MJ, D'Agostino RB Sr, Larson MG, et al: Predicting the 30-year risk of cardiovascular disease: The Framingham Heart Study. Circulation 119: 3078-3084, 2009
27. Colan SD, Parness IA, Spevak PJ, et al: Developmental modulation of myocardial mechanics: Age- and growth-related alterations in afterload and contractility. J Am Coll Cardiol 19:619-629, 1992
28. Sluysmans T, Colan SD: Theoretical and empirical derivation of cardiovascular allometric relationships in children. J Appl Physiol 99:445-457, 2005 (Pubitemid 41061136)
29. Rosenbaum PR: Model-based direct adjustment. J Am Stat Assoc 82:387-394, 1987
30. Austin PC: The relative ability of different propensity score methods to balance measured covariates between treated and untreated subjects in observational studies. Med Decis Making 29:661- 677, 2009
31. Lunceford JK, Davidian M: Stratification and weighting via the propensity score in estimation of causal treatment effects: A comparative study. Stat Med 23:2937-2960, 2004 (Pubitemid 39200133)
32. Schwartz CL, Hobbie WL, Truesdell S, et al: Corrected QT interval prolongation in anthracyclinetreated survivors of childhood cancer. J Clin Oncol 11:1906-1910, 1993 (Pubitemid 23304615)
33. Gupta M, Thaler HT, Friedman D, et al: Presence of prolonged dispersion of QT intervals in late survivors of childhood anthracycline therapy. Pediatr Hematol Oncol 19:533-542, 2002 (Pubitemid 35398074)
34. Lipshultz SE, Shearer WT, Thompson B, et al: Cardiac effects of antiretroviral therapy in HIVnegative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children Cohort Study). J Am Coll Cardiol 57:76-85, 2011
35. Lipshultz SE, Scully RE, Lipsitz SR, et al: Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: Long-term follow-up of a prospective, randomised, multicentre trial. Lancet Oncol 11:950-961, 2010
36. Oeffinger KC, Adams-Huet B, Victor RG, et al: Insulin resistance and risk factors for cardiovascular disease in young adult survivors of childhood acute lymphoblastic leukemia. J Clin Oncol 27:3698-3704, 2009
37. Link K, Moëll C, Garwicz S, et al: Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood. J Clin Endocrinol Metab 89:5003- 5012, 2004
38. Lipshultz SE, Miller TL, Scully RE, et al: Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: Associations with longterm echocardiographic outcomes. J Clin Oncol (in press)
39. Ratnasamy C, Kinnamon DD, Lipshultz SE, et al: Associations between neurohormonal and inflammatory activation and heart failure in children. Am Heart J 155:527-533, 2008
40. Salem M, El Behery S, Adly A, et al: Early predictors of myocardial disease in children and adolescents with type 1 diabetes mellitus. Pediatr Diabetes 10:513-521, 2009
41. van den Berg J, Strengers JL, Wielopolski PA, et al: Assessment of biventricular functional reserve and NT-proBNP levels in patients with RV volume overload after repair of tetralogy of Fallot at young age. Int J Cardiol 133:364-370, 2009
42. Kremastinos DT, Hamodraka E, Parissis J, et al: Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major. Am Heart J 159:68-74, 2010
43. Germanakis I, Kalmanti M, Parthenakis F, et al: Correlation of plasma N-terminal pro-brain natriuretic peptide levels with left ventricle mass in children treated with anthracyclines. Int J Cardiol 108:212-215, 2006 (Pubitemid 43330616)
44. Rusconi PG, Ludwig DA, Ratnasamy C, et al: Serial measurements of serum NT-proBNP as markers of left ventricular systolic function and remodeling in children with heart failure. Am Heart J 160: 776-783, 2010
45. Lipshultz SE, Vlach SA, Lipsitz SR, et al: Cardiac changes associated with growth hormone therapy among children treated with anthracyclines. Pediatrics 115:1613-1622, 2005 (Pubitemid 43843171)
46. Rutter MM, Rose SR: Long-term endocrine sequelae of childhood cancer. Curr Opin Pediatr 19:480-487, 2009 (Pubitemid 47075631)
47. Gurney JG, Ness KK, Sibley SD, et al: Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia. Cancer 107:1303-1312, 2006 (Pubitemid 44452780)
48. Trimis G, Moschovi M, Papassotiriou I, et al: Early indicators of dysmetabolic syndrome in young survivors of acute lymphoblastic leukemia in childhood as a target for preventing disease. J Pediatr Hematol Oncol 29:309-314, 2007 (Pubitemid 46707511)
49. Colao A: The GH-IGF-1 axis and the cardiovascular system: Clinical implications. Clin Endocrinol 69:347-358, 2008
50. Verhelst J, Abs R: Cardiovascular risk factors in hypopituitary GH-deficient adults. Eur J Endocrinol 161:S41-S49, 2009 (suppl 1)
51. van Brussel M, Takken T, Lucia A, et al: Is physical fitness decreased in survivors of childhood leukemia? A systematic review. Leukemia 19:13-17, 2005 (Pubitemid 40090069)
52. Ness KK, Leisenring WM, Huang S, et al: Predictors of inactive lifestyle among adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Cancer 115:1984-1994, 2009
53. Lipshultz SE, Colan SD: Cardiovascular trials in long-term survivors of childhood cancer. J Clin Oncol 22:769-773, 2004 (Pubitemid 41103586)
54. Prospective Studies Collaboration: Blood cholesterol and vascular mortality by age, sex, and blood pressure: A meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths. Lancet 370:1829-1839, 2007
55. Lipshultz SE, Easley KA, Orav EJ, et al: Cardiac dysfunction and mortality in HIV-infected children: The prospective P2C2 HIV multicenter study-Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group. Circulation 102:1542-1548, 2000
56. Fisher SD, Easley KA, Orav EJ, et al: Mild dilated cardiomyopathy and increased left ventricular mass predict mortality: The prospective P2C2 HIV multicenter study. Am Heart J 150:439-447, 2005 (Pubitemid 41317610)
57. Lipshultz SE, Easley KA, Orav EJ, et al: Reliability of multicenter pediatric echocardiographic measurements of left ventricular structure and function. Circulation 104:310-316, 2001 (Pubitemid 32666953)